No disparity of the efficacy and all‐cause mortality between Asian and non‐Asian type 2 diabetes patients with sodium–glucose cotransporter 2 inhibitors treatment: A meta‐analysis

AIMS/INTRODUCTION: To evaluate whether there is disparity of the efficacy and all‐cause mortality and other adverse effects between Asian and non‐Asian patients with sodium–glucose cotransporter 2 (SGLT2) inhibitors treatment. MATERIALS AND METHODS: Randomized clinical trials publicly available befo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiaoling, Gao, Xueying, Yang, Wenjia, Chen, Yifei, Zhang, Simin, Zhou, Lingli, Han, Xueyao, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031489/
https://www.ncbi.nlm.nih.gov/pubmed/29029369
http://dx.doi.org/10.1111/jdi.12760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031489/
https://www.ncbi.nlm.nih.gov/pubmed/29029369
http://dx.doi.org/10.1111/jdi.12760

Ejemplares similares